Intrauterine Devices Market Analysis and Forecast to 2032: By Type (Copper, Hormonal), Age Group (15-24, 25-34, 35-44, Above 44), End-User (Hospitals, Clinics, Community Healthcare Centers, Others), and Region

Intrauterine Devices Market Analysis and Forecast to 2032: By Type (Copper, Hormonal), Age Group (15-24, 25-34, 35-44, Above 44), End-User (Hospitals, Clinics, Community Healthcare Centers, Others), and Region

The global vacuum bearing market was valued at US$ 3.0 billion in 2021 and it is anticipated to grow up to US$ 4.4 billion by 2031, at a CAGR of 3.9% during the forecast period.

An Intrauterine device is a T-shaped plastic or copper birth control medical device inserted into the uterus to prevent pregnancy. It releases copper into the womb, altering the cervical mucus and making it difficult for sperm to reach and survive an egg. It can also prevent a fertilized egg from implanting itself. IUDs are widely preferred over other methods of contraception because they are compact, safe, and cost-effective, and they have no hormonal side effects such as acne, headaches, or breast tenderness. It is currently available in various types that can last for a period of 5 to 10 years.
Global Intrauterine Devices Market Scope and Report Structure
Market Drivers and Trends
The rise in awareness over the availability of the devices through campaigns is the primary driver of the industry's growth. One of the key factors influencing global demand for IUDs are initiatives taken by various countries' health agencies, in collaboration with non-profit organizations (NPOs), to raise awareness about family planning, the benefits of birth control measures, and health-related issues caused by unplanned pregnancies are promoting market growth. Furthermore, because IUDs have a very low risk of ectopic pregnancy, they are gaining popularity among nulliparous women and adolescents who have never given birth and are at a higher risk for negative birth outcomes such as breast and reproductive cancers.

Furthermore, the rise in unplanned and unwanted pregnancies, which has become one of the world's major concerns. For Instance, according to the World Health Organization (WHO) and the International Federation of Medical Students' Associations' 2018 report, approximately 22 million unsafe abortions are performed globally each year, resulting in the deaths of an estimated 47,000 women, Aside from that, the development of advanced product variants with fewer side effects, such as postpartum, slimmer, and reusable IUDs, is expected to offer lucrative growth opportunities to industry investors in the coming years. These factors are expected to drive the growth of the global Intrauterine Devices Market.
Market Restraints and Challenges
The factors that are impeding the market lack of proper knowledge on use of devices, pelvic inflammatory infection, infertility issues, and limited access for conception are limiting the market growth. Additionally, fewer patients experience side effects such as cramps, irregular periods, heavy periods with stronger cramping and others are hindering the global Intrauterine Devices Market growth and further restrict the growth of the market.
Global Intrauterine Devices Market Segmental Overview

The report analyses the global Intrauterine Devices Market based on type, age-group, end-user, and region.

Global Intrauterine Devices Market by Type


Based on type, it is bifurcated into copper, and hormonal. The hormonal segment is expected to be the largest segment in the Intrauterine Devices Market in 2021. Furthermore, because of their numerous health benefits and improved patient outcomes, these hormonal IUDs are recommended by healthcare professionals. Hormonal IUDs are considered extremely safe due to their non-contraceptive benefits and can be used by patients suffering from heavy menstrual bleeding, endometriosis, anaemia, fibroids, and other conditions. Hormonal IUDs prevent pregnancies by thickening the mucus in the cervix and thinned the uterine lining, which partially suppresses ovulation. As a result, the numerous advantages and health benefits provided by hormonal IUDs are expected to drive demand for hormonal IUDs.

Global Intrauterine Devices Market by Age Group

Based on age group, the market is bifurcated into 15-24, 25-34, 35-44, and above 44. The 25-34 segment dominated the market in 2021, because of the increase in awareness of intrauterine devices and a rise in concern about adolescent sexual activity, as premarital and unplanned pregnancy frequently leads to early school termination or abortion.

Global Intrauterine Devices Market by End-User


Based on end-user, the Intrauterine Devices Market is segmented into hospitals, clinics, community healthcare centers and others. The hospital segment dominated the market, because of an increase in the number of patient visits for family planning, which drives market growth during the forecast period.
Geographical Analysis of Global Intrauterine Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America is dominating in the Intrauterine Devices Market. The primary reasons driving the development of the market in this region is the increase in the demand of the copper UID, and hormone based UIDs. According to a 2018 research article 'Contraceptive Use in the United States,' approximately 62 million American women used contraception during their childbearing years (15–44). It was discovered that approximately 43 million of them (70%) are at risk of unintended pregnancy, which means that they are sexually active but do not wish to become pregnant. North America was the second-largest revenue generator in 2021 and is expected to grow at a rapid pace. According to the Centers for Disease Control and Prevention (CDC), 72.2 million U.S. women aged 19 to 49 used contraception from 2018 to 2020. Furthermore, government initiatives have increased birth control awareness and affordability, which is fueling market growth.

Asia-Pacific is anticipated to dominate the market in the upcoming years due to an increase in awareness about the benefits of using hormonal intrauterine devices, the high prevalence of unwanted pregnancy, and favorable regulatory scenarios, which propels the growth of the market.
Major Players in the Global Intrauterine Devices Market
The key players studied in the global Intrauterine Devices Market are Abviee Inc. (US), CooperSurgical Inc. (US), DKT International (US), Eurogine, S.L. (Spain), HLL Lifecare (India), Lupin Pharmaceuticals (India), Mona Lisa NV (Germany), Pregna International Limited (India), Prosan International BV (Netherlands), and Viatris Inc (US) among others.
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the market, because the intrauterine devices market is heavily reliant on physician-administered and physician-prescribed intrauterine devices, the number of patient visits for contraception in hospitals has decreased. However, restrictions on physician office visits without an emergency were imposed during the first few months of the ongoing pandemic. Half of the population considering family planning during COVID-19 shifted their interest from intrauterine devices to other contraception methods such as contraception pills, resulting in a worldwide decline in demand for intrauterine device products. The Health Management Information System, which is part of the Health Ministry's 2020 union, reported that the rate of intrauterine device insertion decreased by 21% during the COVID-19.

According to a research study by Anita Makins, which was published in Gynecology & Obstetrics Journal May 2020, states that there is an huge stock-out of contraceptive methods during the COVID-19 pandemic 2020. Furthermore, the United Nations Population Fund predicted that 46 countries that typically receive supplies from them has experienced stock-outs of one or more modern methods, which includes copper intrauterine devices, implants, oral contraceptive pills, and condoms, over the next six months beginning in May 2020.
Recent Developments

In June 2021, Sebela Pharmaceuticals Inc. is conducting a phase III clinical trial with PRA Health Sciences to evaluate LevoCept, a long-acting reversible intrauterine system, for contraceptive efficacy, safety, and tolerability. The trial is scheduled to conclude in June 2027.
In February 2020, Agile Therapeutics, Inc. received FDA approval for Twirla transdermal system, which is indicated as a method of contraception for use in women of reproductive potential with a BMI of 30 kg/m2 who require a combined hormonal contraceptive.
In September 2019, Kyleena, a Bayer’s intrauterine device, has been approved by the US Food and Drug Administration. This device is extremely effective at preventing pregnancy and has few side effects.

Frequently Asked Questions
Q1. How big is the Intrauterine Devices Market?

Ans. The global Intrauterine Devices Market size was US$ 3.0 billion in 2021 and is anticipated to reach US$ 4.4 billion in 2031, growing at a rate of 3.9% from 2022 to 2031.

Q2. What is the Intrauterine Devices Market growth rate?

Ans. The growth rate of the Intrauterine Devices Market is 3.9% from 2022 to 2031.

Q3. Which region holds a major market share for the Intrauterine Devices Market?

Ans. North America holds a major market share of the Intrauterine Devices Market in 2021.

Q4. Which segment accounted for the largest Intrauterine Devices Market share?

Ans. Based on type, it is bifurcated into copper, and hormonal. The hormonal segment is expected to be the largest segment in the Intrauterine Devices Market in 2021.

Q5. Who are the key players in the Intrauterine Devices Market?

Ans. The global Intrauterine Devices Market report includes players such as Abviee Inc. (US), CooperSurgical Inc. (US), DKT International (US), Eurogine, S.L. (Spain), HLL Lifecare (India), Lupin Pharmaceuticals (India), Mona Lisa NV (Germany), Pregna International Limited (India), Prosan International BV (Netherlands), and Viatris Inc (US) among others.

Q6. What are the factors driving the Intrauterine Devices Market growth?

Ans. The major factors driving the growth of the market are the rise in awareness over the availability of the devices through campaigns and advances in the treatment of cardiac rhythm disorders.

Q7. What are the key growth strategies of Intrauterine Devices Market players?

Ans. The key growth strategies of Intrauterine Devices Market players are product launch, partnerships, and rise in unplanned and unwanted pregnancies.

Q8. Which region will provide more business opportunities for the Intrauterine Devices Market during the forecast period?

Ans. The North America region will provide more business opportunities for the Intrauterine Devices Market during the forecast period.

*Please Note: The report will be delivered in 3-4 business days upon order confirmation*